RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BORZUMATI M
Collezione ASL Vercelli

Items : 3

Increase of continuous treatments and regional citrate anticoagulation during renal replacement therapy in the ICUs of the North-West of Italy from 2007 to 2015. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Jun;75(3):388-397. doi: 10.23736/S2724-6051.22.04699-7. Epub 2022 Mar 11.

2023
ASL Asti
AO Cuneo
ASL Città di Torino
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mariano F; Biancone L; Roccatello D; Cusinato S; Besso L; Cesano G; Boero R; Vitale C; Chiarinotti D; Manganaro M; Filiberti O; Costantini L; Borzumati M; Vio P; Chiappero F; Todini V; Marciello A; Savoldi S; Deagostini C; Martina G; Serra A; Stramignoni E; Salomone M; Formica M; Marino A; Maffei S; Roscini E; Calabrese G; Gherzi M; et alii...

Effectiveness of Switch to Erythropoiesis-Stimulating Agent (ESA) Biosimilars versus Maintenance of ESA Originators in the Real-Life Setting: Matched-Control Study in Hemodialysis Patients. in Clinical drug investigation / Clin Drug Investig. 2017 Oct;37(10):965-973. doi: 10.1007/s40261-017-0562-8.

2017
ASL Vercelli

Minutolo R; Bolasco P; Chiodini P; Sposini S; Borzumati M; Abaterusso C; Mele AA; Santoro D; Canale V; Santoboni A; Filiberti O; Fiorini F; Mura C; Imperiali P; Borrelli S; Russo L; De Nicola L; Russo D;

Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients. in American journal of kidney diseases : the official journal of the National Kidney Foundation / Am J Kidney Dis. 2016 Jul;68(1):170-2. doi: 10.1053/j.ajkd.2016.01.011. Epub 2016 Feb 13.

2016
ASL Vercelli

Minutolo R; Borzumati M; Sposini S; Abaterusso C; Carraro G; Santoboni A; Mura C; Filiberti O; Santoro D; Musacchio R; Imperiali P; Fiorini F; De Nicola L; Russo D;